AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14563144 — intervention group
Group type: COMPARATOR
Intervention: No preoperative irradiation (control group)
Number of subjects: 10
Study 10364951 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol (IPA) wipes before venesection
Number of subjects: 194
Study 10364951 — intervention group
Group type: COMPARATOR
Intervention: No isopropyl alcohol (IPA) wipes before venesection
Number of subjects: 194
Study 8896099 — intervention group
Group type: EXPERIMENTAL
Intervention: Kennedy ligament augmentation device (LAD)
Number of subjects: 82
Study 8896099 — intervention group
Group type: COMPARATOR
Intervention: No augmentation (non-augmented knee group)
Number of subjects: 82
Study 2050831 — intervention group
Group type: EXPERIMENTAL
Intervention: HCTZ 50 mg daily
Number of subjects: 9
Study 2050831 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 10 mg daily
Number of subjects: 9
Study 2050831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 6084123 — intervention group
Group type: EXPERIMENTAL
Intervention: guanabenz 16 mg/hydrochlorothiazide 25 mg (combination tablet)
Number of subjects: 24
Study 6084123 — intervention group
Group type: COMPARATOR
Intervention: hydrochlorothiazide 25 mg (alone)
Number of subjects: 24
Study 31722312 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection with E0302 50 mg, twice a week for 16 weeks
Number of subjects: 128
Study 31722312 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice a week for 16 weeks
Number of subjects: 128
Study 28571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 0
Study 28571119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25299501 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (TH)
Number of subjects: 21
Study 25299501 — intervention group
Group type: COMPARATOR
Intervention: Historical control (no hypothermia)
Number of subjects: 21
Study 23480216 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350+E (26 g split dose daily)
Number of subjects: 240
Study 23480216 — intervention group
Group type: COMPARATOR
Intervention: Prucalopride (1-2 mg daily)
Number of subjects: 240
Study 23480216 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350+E
Number of subjects: 240
Study 23480216 — intervention group
Group type: COMPARATOR
Intervention: Prucalopride
Number of subjects: 240
Study 21676229 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive cardiac output monitoring for 24 hours (MICO group)
Number of subjects: 388
Study 21676229 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 388
Study 21676229 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive cardiac output monitoring (MICO group)
Number of subjects: 388
Study 19170454 — intervention group
Group type: EXPERIMENTAL
Intervention: MI with feedback
Number of subjects: 279
Study 19170454 — intervention group
Group type: COMPARATOR
Intervention: MI without feedback
Number of subjects: 279
Study 19170454 — intervention group
Group type: COMPARATOR
Intervention: Feedback alone
Number of subjects: 279
Study 19170454 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 279
Study 16832133 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding via nasojejunal tube with study feed containing glutamine, arginine, tributyrin and antioxidants for 3 days
Number of subjects: 31
Study 16832133 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous control feed
Number of subjects: 31
Study 15107913 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA gel (pH 7.0) at concentrations of 5%, 10%, 15%, 20%, and 24% (n = 100)
Number of subjects: 220
Study 15107913 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA-T gel (pH 7.0) at concentrations of 5%, 10%, 15%, 20%, and 24% (n = 100)
Number of subjects: 220
Study 15107913 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline solution, n = 20)
Number of subjects: 220
Study 11707790 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (EF) - 17 mL of 2% lidocaine plus 100 microg fentanyl
Number of subjects: 36
Study 11707790 — intervention group
Group type: COMPARATOR
Intervention: IV fentanyl (IF) - 17 mL of 2% lidocaine plus 2 mL of normal saline followed by IV injection of 100 microg of fentanyl
Number of subjects: 36
Study 11707790 — intervention group
Group type: COMPARATOR
Intervention: Control (C) - 17 mL of 2% lidocaine plus 2 mL of normal saline followed by IV injection of 2 mL of normal saline
Number of subjects: 36
Study 9206952 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term artificial pulmonary ventilation and feeding through a naso-gastric probe
Number of subjects: 18
Study 9206952 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsies of n. suralis taken at different periods after the appearance of the first signs of DP
Number of subjects: 18
Study 9206952 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy studies (light and electronic)
Number of subjects: 18
Study 7960161 — intervention group
Group type: EXPERIMENTAL
Intervention: High level interventions
Number of subjects: 1585
Study 7960161 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium level interventions
Number of subjects: 1585
Study 7960161 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level interventions
Number of subjects: 1585
Study 7960161 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall work effort
Number of subjects: 1585
Study 2880213 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination vaccine (live BCG + killed leishmania promastigotes)
Number of subjects: 94
Study 2880213 — intervention group
Group type: COMPARATOR
Intervention: Standard antimonial regimen (meglumine antimonate)
Number of subjects: 94
Study 31430059 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline cleaning
Number of subjects: 128
Study 31430059 — intervention group
Group type: COMPARATOR
Intervention: Routine cleaning
Number of subjects: 128
Study 29255961 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-incision laparoscopic cholecystectomy
Number of subjects: 0
Study 29255961 — intervention group
Group type: COMPARATOR
Intervention: Conventional four-port laparoscopic cholecystectomy
Number of subjects: 0
Study 27431595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 868
Study 27431595 — intervention group
Group type: COMPARATOR
Intervention: Propofol-based TIVA
Number of subjects: 868
Study 24139497 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/Salmeterol
Number of subjects: 611
Study 24139497 — intervention group
Group type: COMPARATOR
Intervention: 2.5× Fluticasone
Number of subjects: 611
Study 24139497 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone/Montelukast
Number of subjects: 611
Study 24139497 — intervention group
Group type: COMPARATOR
Intervention: Leukotriene Receptor Antagonist and Inhaled Corticosteroid
Number of subjects: 611
Study 23497032 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment at 6 standard acupuncture points (ST36, ST35, ST34, SP9, Ex‐LE04, and SP10) 3 times per week for 4 weeks (total of 12 sessions)
Number of subjects: 212
Study 23497032 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no moxibustion treatment)
Number of subjects: 212
Study 23497032 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment
Number of subjects: 212
Study 23497032 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 21460709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (0.6 mg/kg/day, 48 hrs)
Number of subjects: 145
Study 21460709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 17904718 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide feasibility study participation
Number of subjects: 21
Study 16546850 — intervention group
Group type: EXPERIMENTAL
Intervention: TMD treatment
Number of subjects: 120
Study 16546850 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 120
Study 12689776 — intervention group
Group type: EXPERIMENTAL
Intervention: Static lumbar flexion for 10 minutes
Number of subjects: 0
Study 10891474 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic telomere length measurement using Southern blot hybridization with (TTAGGG)(4) probe
Number of subjects: 59
Study 10891474 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-adjusted TRA reduction
Number of subjects: 59
Study 8649241 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-supplemented formula (0.2% docosahexaenoic acid from marine oil)
Number of subjects: 0
Study 8649241 — intervention group
Group type: COMPARATOR
Intervention: Control formula (without DHA)
Number of subjects: 0
Study 1399355 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-tube (O-T) technique
Number of subjects: 102
Study 1399355 — intervention group
Group type: COMPARATOR
Intervention: Free-hand (F-H) technique
Number of subjects: 102
Study 3528612 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril or prazosin treatment in Group I patients
Number of subjects: 25
Study 3528612 — intervention group
Group type: COMPARATOR
Intervention: Group I patients (elevated vasopressin)
Number of subjects: 25
Study 29370120 — intervention group
Group type: EXPERIMENTAL
Intervention: VMP (dietary multivitamin, multimineral and phytonutrient supplement)
Number of subjects: 120
Study 29370120 — intervention group
Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 120
Study 27196148 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity and diet intervention
Number of subjects: 401
Study 24874533 — intervention group
Group type: EXPERIMENTAL
Intervention: Facet corticosteroid injections
Number of subjects: 56
Study 24874533 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal corticosteroid injections
Number of subjects: 56
Study 22398670 — intervention group
Group type: EXPERIMENTAL
Intervention: Edema index-guided case management (EI)
Number of subjects: 159
Study 22398670 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 159
Study 22398670 — intervention group
Group type: COMPARATOR
Intervention: Case management (CM)
Number of subjects: 159
Study 20639746 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency percussive ventilation
Number of subjects: 62
Study 20639746 — intervention group
Group type: COMPARATOR
Intervention: Low-tidal volume ventilation
Number of subjects: 62
Study 18716158 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-rich diet (38% total fat, 22% MUFA)
Number of subjects: 59
Study 18716158 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-rich diet (30% total fat, 55% carbohydrate)
Number of subjects: 59
Study 18716158 — intervention group
Group type: COMPARATOR
Intervention: SFA-rich diet (38% total fat, 20% SFA)
Number of subjects: 59
Study 18716158 — intervention group
Group type: COMPARATOR
Intervention: C/C women
Number of subjects: 59
Study 17142217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg intravenously before surgery
Number of subjects: 30
Study 17142217 — intervention group
Group type: COMPARATOR
Intervention: No medication administered (Control)
Number of subjects: 30
Study 12692753 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril (ACE inhibitor)
Number of subjects: 36
Study 12692753 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (ARB)
Number of subjects: 36
Study 12692753 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril plus Valsartan (combination therapy)
Number of subjects: 36
Study 10750754 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard heparinization (group S; 300 IU/kg initially; ACT > 480 seconds; 5,000 IU in prime)
Number of subjects: 30
Study 10750754 — intervention group
Group type: COMPARATOR
Intervention: Reduced heparinization (group R; 100 IU/kg initially; ACT > 250 seconds; 2,500 IU in prime)
Number of subjects: 30
Study 8959161 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mmol MgCl2 (low)
Number of subjects: 0
Study 8959161 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mmol MgCl2 (high)
Number of subjects: 0
Study 8959161 — intervention group
Group type: COMPARATOR
Intervention: 0 mmol MgCl2 (control)
Number of subjects: 0
Study 8959161 — intervention group
Group type: EXPERIMENTAL
Intervention: A23187 with 1 mmol MgCl2 (low)
Number of subjects: 0
Study 8959161 — intervention group
Group type: EXPERIMENTAL
Intervention: A23187 with 10 mmol MgCl2 (high)
Number of subjects: 0
Study 8959161 — intervention group
Group type: COMPARATOR
Intervention: A23187 with 0 mmol MgCl2 (control)
Number of subjects: 0
Study 1396643 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 14
Study 2933253 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ketanserin
Number of subjects: 20
Study 2933253 — intervention group
Group type: COMPARATOR
Intervention: 10 ml saline (placebo)
Number of subjects: 20
Study 30443883 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) plus exercise
Number of subjects: 84
Study 30443883 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound (US) treatment and Transcutaneous Nerve Stimulation (TENS) plus exercise
Number of subjects: 84
Study 27498173 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching group (verbal encouragement and visual cue)
Number of subjects: 30
Study 27498173 — intervention group
Group type: COMPARATOR
Intervention: Non-coaching group (no coaching)
Number of subjects: 30
Study 26063002 — intervention group
Group type: EXPERIMENTAL
Intervention: Quaternary ammonium compound-based sanitizing wipe used at least once per day
Number of subjects: 5
Study 23222844 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced respiration
Number of subjects: 0
Study 23222844 — intervention group
Group type: COMPARATOR
Intervention: Attention control (fast, shallow breathing)
Number of subjects: 0
Study 23222844 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 21727151 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous exercise (MICE) at 70% of the maximal HR of the graded maximal exercise test (n=10)
Number of subjects: 27
Study 21727151 — intervention group
Group type: EXPERIMENTAL
Intervention: MICE at the maximal 6MWT HR (n=8)
Number of subjects: 27
Study 21727151 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) based on the 6MWT and the 200-mFWT maximal HR (n=9)
Number of subjects: 27
Study 19794123 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in a 14-month trial of oral glatiramer acetate)
Number of subjects: 906
Study 19794123 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in a 3-year trial of interferon beta-1b)
Number of subjects: 906
Study 19794123 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in both trials)
Number of subjects: 906
Study 16488348 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive intervention including an information pack and Fatigue Diary, monthly support nurse visits for three months
Number of subjects: 103
Study 16488348 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive intervention
Number of subjects: 103
Study 12892594 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g intravenously 0.5 - 1 h prior to operation)
Number of subjects: 305
Study 12892594 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime (0.75 g preoperatively and the same dose q8h for 3 d)
Number of subjects: 305
Study 12892594 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 305
Study 12892594 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 305
Study 11049007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen gel
Number of subjects: 15
Study 11049007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9349064 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised lignocaine (4 ml 4% lignocaine)
Number of subjects: 75
Study 9349064 — intervention group
Group type: COMPARATOR
Intervention: Nebulised saline (4 ml 0.9% NaCl)
Number of subjects: 75
Study 8260897 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (125 micrograms/m2/day) for 14 days
Number of subjects: 62
Study 8260897 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 62
Study 3845028 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg Sulprostone gel
Number of subjects: 40
Study 3845028 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg Sulprostone gel
Number of subjects: 40
Study 31683351 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Vertical Loop (DVL) suture configuration
Number of subjects: 22
Study 31683351 — intervention group
Group type: COMPARATOR
Intervention: Single Vertical Loop (SVL) suture configuration
Number of subjects: 22
Study 29452809 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 36
Study 29452809 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 36
Study 29452809 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with remifentanil
Number of subjects: 36
Study 28060360 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 72
Study 28060360 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 72
Study 26523885 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-module internet-delivered cognitive behavioral therapy (iCBT) program
Number of subjects: 96
Study 26523885 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 96
Study 23348981 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (3000 mg per day)
Number of subjects: 26
Study 23348981 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 26
Study 21511500 — intervention group
Group type: EXPERIMENTAL
Intervention: EMONO inhalation
Number of subjects: 99
Study 21511500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 17973947 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT‐MPA (conjugated oestrogen plus medroxyprogesterone acetate)
Number of subjects: 104
Study 17973947 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT‐NET (conjugated oestrogen plus norethisterone)
Number of subjects: 104
Study 17973947 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 104
Study 16472368 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based program including depression screening and group activity
Number of subjects: 1685
Study 16472368 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical trend)
Number of subjects: 1685
Study 12862363 — intervention group
Group type: COMPARATOR
Intervention: Cyclical etidronate (200 mg daily for 2 weeks every 3 months) for 18 months
Number of subjects: 40
Study 12862363 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical etidronate for 12 months followed by alendronate (5 mg daily) for 6 months
Number of subjects: 40
Study 10547251 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate (Augmentin) 45 mg/kg/d in 2 divided doses for 10 days
Number of subjects: 106
Study 10547251 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (Zithromax), 10 mg/kg on the first day, followed by 5 mg/kg daily for 4 days
Number of subjects: 106
Study 10547251 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Amoxicillin/clavulanate and Azithromycin)
Number of subjects: 106
Study 8921795 — intervention group
Group type: EXPERIMENTAL
Intervention: 130-J truncated biphasic waveform
Number of subjects: 294
Study 8921795 — intervention group
Group type: COMPARATOR
Intervention: 200-J damped sine wave monophasic waveform
Number of subjects: 294
Study 1885826 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% lidocaine jelly
Number of subjects: 0
Study 6889218 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (propranolol + nifedipine)
Number of subjects: 26
Study 6889218 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone
Number of subjects: 26
Study 6889218 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine alone
Number of subjects: 26
Study 6889218 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine monotherapy
Number of subjects: 26
Study 31690151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-saccular flow diversion (ISFD) using the Woven Endo-Bridge (WEB) device
Number of subjects: 250
Study 31690151 — intervention group
Group type: COMPARATOR
Intervention: Best conventional management option (surgical or endovascular)
Number of subjects: 250
Study 29898352 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer group education by trained former patients
Number of subjects: 70
Study 29898352 — intervention group
Group type: COMPARATOR
Intervention: Routine instructions by department's nurses
Number of subjects: 70
Study 26679079 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release (ER) niacin
Number of subjects: 12
Study 24408212 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (active medication)
Number of subjects: 88
Study 24408212 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 88
Study 22200391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically imposed stiff-knee gait (SKG-M) using a lockable knee brace
Number of subjects: 20
Study 22200391 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologically imposed stiff-knee gait (SKG-P) using electrical stimulation to the quadriceps
Number of subjects: 20
Study 22200391 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 22200391 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologically imposed stiff-knee gait (SKG-P)
Number of subjects: 20
Study 20028707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg, once daily
Number of subjects: 250
Study 20028707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 5.0 mg, once daily (switched to 1.25 mg during months 15-24)
Number of subjects: 250
Study 20028707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 20028707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (both doses)
Number of subjects: 250
Study 16871270 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label sildenafil (50 mg adjustable to 100 mg)
Number of subjects: 50